Showing results (491-500 of 3,353) with videos related to

Sort By:
Pageof 336
The Lancet. Oncology|August 2, 2025
Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant prostate cancer in ENZA-p (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trialLouise Emmett, Nathan Papa, Shalini Subramaniam, et al.
The Lancet. Oncology|September 17, 2013
Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysisWei-Chih Liao, Kuo-Liong Chien, Yu-Lin Lin, et al.
The Lancet. Oncology|August 1, 2014
Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric OncologyJean-Pierre Droz, Matti Aapro, Lodovico Balducci, et al.
The Lancet. Oncology|December 4, 2013
Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trialSung Won Choi, Thomas Braun, Lawrence Chang, et al.
The Lancet. Oncology|September 3, 2013
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO groupNancy U Lin, Jeffrey S Wefel, Eudocia Q Lee, et al.
The Lancet. Oncology|December 7, 2013
Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 studyKaoru Kubota, Toyoaki Hida, Satoshi Ishikura, et al.
The Lancet. Oncology|January 22, 2013
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trialDan Stark, Matthew Nankivell, Eric Pujade-Lauraine, et al.
The Lancet. Oncology|May 18, 2013
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' dataAudrey Mauguen, Jean-Pierre Pignon, Sarah Burdett, et al.
The Lancet. Oncology|May 21, 2013
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort studyThorsten Kuehn, Ingo Bauerfeind, Tanja Fehm, et al.
The Lancet. Oncology|April 9, 2013
Cancer in EthiopiaYohannes W Woldeamanuel, Belaineh Girma, Alula M Teklu
Pageof 336